Overview
Portfolio
More
Solidusvc
New York, United States
AI-powered trade surveillance and threat intelligence to ensure market integrity across securities, crypto, and other financial assets.
Portfolio
99+
Employees
50+
Founded
2018
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Solidusvc
AI-powered trade surveillance and threat intelligence to ensure market integrity across securities, crypto, and other financial assets.
Portfolio
99+
Employees
50+
Founded
2018
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 24 of 49 matched portfolio companies
1STBIO develops novel therapeutics targeting neurodegenerative diseases, immuno-oncology, and rare diseases through a genomic-based target discovery platform. The company addresses significant unmet medical needs by transforming breakthrough scientific discoveries into effective medicines for patients.
The startup produces plant-based microbial oils by cultivating microorganisms that generate beneficial fatty acids, antioxidants, and pigments. This technology provides a sustainable alternative to traditional vegetable oils and animal fats, promoting healthier polyunsaturated fat options for various industries.
Funding: $7.7M
Rough estimate of the amount of funding raised
Funding: $7.7M
Rough estimate of the amount of funding raised
AITRICS provides a data-driven health intelligence platform that enables users to access and analyze health data for improved decision-making. The platform addresses the challenge of fragmented health information by offering a unified interface for personalized health insights.
The startup develops human hyaluronidase technology to enhance the delivery of therapeutics for complex health conditions. This technology improves the efficacy of treatments by facilitating the dispersion of medications in tissues, thereby aiding in patient recovery.
BIK is an AI-driven marketing platform that consolidates eCommerce marketing and customer support across channels like Instagram and WhatsApp, enhancing engagement through personalized interactions and real-time analytics. The platform addresses low conversion rates and high customer acquisition costs by delivering targeted marketing and efficient support solutions, resulting in measurable increases in ROI for brands.
The startup develops a deep learning-based platform for automated digital dental systems that supports remote diagnosis through advanced medical image analysis and extensive clinical data storage. This technology enables dental clinics to enhance diagnostic accuracy and streamline treatment options, improving patient care and operational efficiency.
The startup offers a diabetes management platform that enables patients to track their blood glucose levels, daily exercise, and dietary supplements through integrated communication tools and personal consultations with healthcare professionals. This platform provides actionable insights to help users maintain optimal glucose control and improve their overall health management.
Eon transforms cloud backups into instantly accessible, strategic assets through a new storage tier designed for efficiency and control. The platform provides automated backup posture management, global search capabilities, and granular restoration for compliance and faster recovery. This cloud-native solution eliminates hidden costs and offers ransomware protection across multi-cloud environments.
Funding: $197.0M
Rough estimate of the amount of funding raised
Funding: $197.0M
Rough estimate of the amount of funding raised
The startup has developed a real-time fall detection system for senior citizens in nursing homes that utilizes presence detection, actigraphy, and biometric analysis of heart and breath rhythms without the need for sensors or cameras. This technology provides early alerts to caregivers, enhancing patient safety and response times in critical situations.
1000+
Approximate amount of employees
The startup offers a safety management platform that utilizes non-contact biosignal measurement technology to monitor vital signs such as blood pressure, pulse, and oxygen saturation through a camera. This enables businesses to enhance workplace safety and efficiency by providing real-time data monitoring and alerts for abnormal conditions without physical contact.
Geninus provides clinical genome analysis solutions utilizing advanced genetic testing technologies, including disease prediction and liquid biopsy for cancer genomics. The company enhances individual health management and contributes to public health by delivering personalized insights based on genomic characteristics.
H Company develops AI models, including VLMs and LLMs, to automate web processes and enhance decision-making for businesses. Their technology increases worker productivity by streamlining repetitive tasks and improving operational efficiency.
Funding: $220.0M
Rough estimate of the amount of funding raised
Funding: $220.0M
Rough estimate of the amount of funding raised
The startup develops human microbiota utilizing differentiated separation technology for anaerobic intestinal microbe strains, targeting the prevention of diverse diseases and enhancing cancer immunotherapy. Their approach enables physicians to perform multi-omics analysis, facilitating clinical research and drug discovery in metabolic and brain diseases.
Hisense Bio develops dental therapeutics utilizing Cell Activation Technology to regenerate dental tissues, specifically targeting intractable conditions such as dentin hypersensitivity, dental caries, and periodontal disease. Their approach enhances the activation of odontoblasts and periodontal ligament fibroblasts, providing a novel treatment option for patients suffering from these persistent dental issues.
JIT provides an Open Application Security Posture Management (ASPM) platform that automates security testing and vulnerability remediation directly within developers' integrated development environments (IDEs). This enables teams to identify and resolve security issues in real-time, reducing the complexity of managing multiple security tools and ensuring consistent protection before code deployment.
Funding: $46.7M
Rough estimate of the amount of funding raised
Funding: $46.7M
Rough estimate of the amount of funding raised
JLK develops AI-driven medical software that utilizes advanced data analysis techniques for the precise diagnosis and treatment of stroke, significantly reducing the time from symptom onset to intervention. Their MEDIHUB STROKE platform integrates various medical imaging modalities to enhance workflow efficiency and improve patient outcomes in both acute and chronic stroke management.
KANAPH Therapeutics uses a genomics‑driven platform to discover disease signatures and translate them into next‑generation therapeutics for solid‑tumor oncology and ocular diseases. The company integrates human genome analysis with protein engineering to create bispecific antibodies, synthetic small‑molecule pipelines, and advanced ADCs featuring hydrophilic linkers and customizable payloads, delivering highly selective candidates from target validation through preclinical and early clinical stages.
The startup develops a virtual reality-based ophthalmology test device that quantitatively measures eye movements to conduct field of vision and diplopia tests. This technology enables accurate diagnosis of eye diseases such as glaucoma, macular degeneration, and cataracts, providing users with accessible medical examination services.
Mandenn provides a suite of tools designed to enhance career management by focusing on performance improvement, skills development, relationship building, and personal branding. The platform addresses the challenge of navigating post-employment transitions and maximizing opportunities for career advancement.
The startup offers an on-demand matching platform that utilizes algorithms to connect service providers with customers in sectors like moving, cleaning, mortgage, and education. This platform enhances service providers' visibility and helps them expand their client base by efficiently aligning customer needs with available services.
The startup develops micro-engineered physiological systems that replicate organ-level functions using connected human tissues, providing a more accurate alternative to traditional 2D cell culture for biological research. This technology enables researchers to validate new biological mechanisms in a physiologically relevant environment, enhancing the drug discovery process.
Neuramedy conducts research on neurodegenerative disorders, specifically targeting alpha-synuclein and TLR2 to prevent its propagation and associated neuroinflammation in Parkinson's disease. The company collaborates with industry and academia to develop therapeutic solutions that address the underlying mechanisms of these age-related conditions.
Nexcera develops eye-drop therapeutics and a delivery platform utilizing recombinant protein polymer technology to enhance drug efficacy and patient compliance in ocular treatments. The company addresses the challenges of effective drug delivery and sustainability in the medical field, providing reliable solutions for patients and healthcare providers.
Nora develops mentr.ai, a platform that provides real-time AI assistance during meetings by automatically joining calls, conducting research, and delivering tailored input based on user-defined goals. This technology enhances meeting efficiency and decision-making by offering actionable insights and summaries, thereby reducing the time spent on preparation and follow-ups.
Showing 12 of 50 unmatched portfolio companies